NCT04542616Completed
Baerveldt 350 vs Ahmed ClearPath 250 for the Treatment of Glaucoma
Outcomes Comparison Between Baerveldt 350 and Ahmed ClearPath 250 Tube Shunts for the Treatment of Glaucoma
Source: ClinicalTrials.gov · Last updated 17 Apr 2026
Brief summary (registry, in English)
To compare the safety and efficacy of Baerveldt 350 and Ahmed ClearPath 250 tube shunts in lowering IOP in glaucoma patients.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 80 (actual)
- First submitted
- 27 Aug 2020
- Start date
- 13 Aug 2020
- Primary completion date
- 31 Jul 2024
- Lead sponsor
- State University of New York at Buffalo
- Diseases
- Glaucoma
- NCT number
- NCT04542616
What you commit to
- Study type: Interventional
- Participants enrolled: 80
- From 13 Aug 2020 to the primary completion date, 31 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Phakic eyes (no previous cataract surgery).
- Aphakic eyes (status post previous cataract removal but without a lens implant).
Age
- Age \<18 years.
- Women of child-bearing age.
Other
- Patients unable to comprehend and sign the study consent form.
- Women who are pregnant.
Who the study is looking for
- Significant uncontrolled glaucoma despite medical, laser or previous surgical therapy that requires tube shunt implantation as standard-of-care to stabilize the glaucoma and preserve vision.
- Pseudophakia
- Patients who are willing to participate and are able to understand and sign the study consent form.
- Age ≥18 years.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Ira G. Ross Eye Institute Coordinator of this site? Confirm its status | Buffalo | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.